IP Library Granted Patent US 8,546,335
Granted Patent B2
US 8,546,335 · App. 13/265,045 · Granted Oct 1, 2013

Peptidic hydrolyzate proteasome activators and compositions containing same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,546,335
App. No.
13/265,045
Granted
Oct 1, 2013
Kind
B2
Abstract

The present invention concerns a peptidic hydrolyzate enriched in bioactive peptides, said hydrolyzate being a proteasome activator. Further, the present invention concerns a cosmetic or pharmaceutical composition comprising said hydrolyzate in a physiologically acceptable medium and also its use in treating signs of aging or photo-aging in skin and protecting the skin against challenges by ultraviolet radiation. Finally, the invention concerns a cosmetic treatment method intended to treat the signs of skin aging and photo-aging.

Claims (25)

1. A method for treating the signs of skin aging and photo-aging or treating against photo-aging, the method comprising:

providing a proteasome activating peptidic hydrolyzate from corn, pea, yeast or rice comprising bioactive peptides, with a molecular weight of less than 6 kDa, comprising from 3 to 5 amino acids, each bioactive peptide comprising at least one aspartic acid, one cysteine residue, and an arginine residue, wherein the bioactive peptide is selected from the group consisting of:

(SEQ ID No. 1)

Arg-Asp-Cys-Arg-Arg,

(SEQ ID No. 2)

Asn-Asp-Cys-Arg-Lys,

(SEQ ID No. 3)

Asp-Cys-Arg-His,

(SEQ ID No. 4)

Val-Asp-Cys-Arg,

and

(SEQ ID No. 5)

Asp-Cys-Arg;

topically applying an effective quantity of said peptidic hydrolyzate to the skin, the nails or the hair to be treated.

2. The method according to claim 1 , wherein providing the proteasome activating peptidic hydrolyzate in a cosmetic composition.

3. The method according to claim 2 , wherein said cosmetic composition comprises a cosmetically acceptable medium.

4. The method of claim 2 , wherein said peptidic hydrolyzate is present in the cosmetic composition in a quantity from 0.0001% to 20% of the total weight of the composition.

5. The method of claim 2 , wherein the peptidic hydrolyzate is present in the cosmetic composition in a quantity from 0.05% to 5% of the total weight of the composition.

6. The method of claim 2 , wherein the cosmetic composition further comprises one or more solvents selected from the group consisting of water, glycerol, ethanol, propylene glycol, butylene glycol, dipropylene glycol, ethoxylated or propoxylated diglycols, cyclic polyols, white petroleum jelly, a vegetable oil, and combinations thereof, said peptidic hydrolyzate being dissolved therein.

7. The method of claim 2 , wherein the cosmetic composition further comprises at least one active principle promoting the action of said peptidic hydrolyzate selected from the group consisting of a free radical scavenger, an antioxidant, vitamins, phytosterols, flavonoids, dehydroepiandrosterone (DHEA), a metalloproteinase inhibitor, or a retinoid.

8. The method of claim 1 , further comprising isolating said peptidic hydrolyzate from hydrolysis of plants selected from corn ( Zea mayz L.), pea ( Pisum sativum ), or rice ( Oryza sativa L.).

9. The method of claim 1 , further comprising isolating said peptidic hydrolyzate from hydrolysis of yeasts of the Saccharomyces genus.

10. The method of claim 9 , wherein isolating said peptidic hydrolyzate is from Saccharomyces cerevisiae.

11. The method of claim 1 , wherein said peptidic hydrolyzate contains between 0.5 and 5.5 g/l of the bioactive peptide.

12. The method of claim 1 , wherein signs of aging in skin includes wrinkles, deep and coarse wrinkles, fine lines, cracks, the slackening of skin and subcutaneous tissues, the loss of skin elasticity and atony, the loss of firmness and skin tonicity, and dermal atrophy.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2012
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 028867/0966 →